Canada

December 6, 2017December 7, 2017

National MS Society Endorses US-Canada Registry Aiming to Advance Research and Patient Care

News

The National Multiple Sclerosis Society has endorsed the North American Registry for Care and Research in Multiple Sclerosis, a collaborative effort involving other multiple sclerosis registries, ... Read more

December 6, 2017December 7, 2017

Health Canada Approves Merck’s Mavenclad to Treat RRMS

News

Canadians with relapsing-remitting multiple sclerosis can now receive Merck’s Mavenclad, now that Health Canada has approved Mavenclad as a therapy to reduce the frequency of MS exacerbations and delay ... Read more

October 27, 2017October 27, 2017

#MSParis2017 – Beta-Interferon Therapies May Increase Survival of MS Patients, Study Suggests

News

Long-term exposure of at least three years of beta-interferon therapies such as Rebif or Avonex may increase the survival of multiple sclerosis (MS) patients, a population-based study ... Read more

September 6, 2017September 6, 2017

Older Women with MS Age Better Than Their Male Counterparts, Canadian Survey Finds

News

Older men with multiple sclerosis (MS) have more harmful lifestyles than older women with the disease, concludes the Canadian Survey of Health, Lifestyle and Aging with Multiple Sclerosis. ... Read more

July 26, 2017July 27, 2017

Wealthy Oilman with Multiple Sclerosis Funds Canadian Studies for Promising MS Therapy

News

Canadian oilman Hank Swartout made a fortune as longtime founder and CEO of Precision Drilling. The Calgary native mortgaged his house to start the company, which ... Read more

July 6, 2017July 6, 2017

Younger MS Patients Who Are Hospitalized May Be at Higher Risk of Quitting Treatment, Study Reports

News

MS patients who start treatment at a younger age, and whose condition requires hospitalization, are more likely to stop treatment, a Canadian study reports. The research, published ... Read more

June 8, 2017June 8, 2017

‘MS from the Inside Out’ Uses Virtual Reality to Share What Life for Patients Is Like

News

Virtual reality (VR) technology is most commonly associated with gaming and entertainment, but it’s expanding into a variety of clinical and healthcare applications. The Ontario-based biopharmaceutical firm EMD Serono, ... Read more

May 30, 2017May 30, 2017

#CMSC17 – Physical Activity Halts Depression in Young MS Patients, Canadian Study Shows

News

Young multiple sclerosis (MS) patients who engage in physical activity can relieve symptoms of depression, concludes a Canadian study supported by the National Multiple Sclerosis Society. Researchers ... Read more

April 27, 2017April 27, 2017

MS Patients Seem to Present Earlier Symptoms of Disease Before Diagnosis

News

Patients with multiple sclerosis (MS) may be developing the disease for up to five years before the first clinical diagnosis is made, a study has found. ... Read more

March 30, 2017March 30, 2017

Hope, But No Cheers Yet, Voiced by MS Groups in Europe and Canada Waiting on Own Ocrevus Decision

News

American patient groups and neurologists have clearly been giving Ocrevus (ocrelizumab) plenty of attention since news of its approval landed, as a sweep of U.S. reaction to the ... Read more

February 16, 2017February 16, 2017

Researchers Test Medical Cannabis as Treatment for MS-Linked Neuropathic Pain

News

Canadian researchers are testing mice to see if cannabinoid oil products — a common medical marijuana treatment — could help alleviate the neuropathic pain that often afflicts patients with ... Read more

January 31, 2017January 31, 2017

Tennessee Neurologist to Lead $8.4M MS Research Program at University of Saskatchewan

News

The University of Saskatchewan‘s incoming Chair in Multiple Sclerosis Clinical Research will have a research endowment worth $8.4 million to help him search for a cure for multiple sclerosis (MS). ... Read more

January 12, 2017January 13, 2017

Proximity to Heavy Traffic Raises Dementia Risk – But Not That of MS, Study Finds

News

The effect air and noise pollution can have on the development of neurodegenerative diseases is not fully understood, but results from a large study published in ... Read more

November 10, 2016November 10, 2016

Canadian Firm Opens Clinics to Train People Using Its Keeogo Walking Assistance Device

News

B-Temia announced the launch of its “b-Klinic Mobility” business unit, offering clinical services, information, training, and ongoing support to patients and healthcare professionals who use the company’s Keeogo ... Read more

September 9, 2016September 9, 2016

5 Canadians Studying for Future in Multiple Sclerosis Research Awarded Scholarships

News

The Multiple Sclerosis Society of Canada (MSSC) recently announced that five university students — either diagnosed with or affected by multiple sclerosis (MS) — were the 2016 recipients of scholarships worth up ... Read more

August 29, 2016August 29, 2016

Lemtrada to Treat Relapsing MS Now Part of New Brunswick, Canada, Drug Program

News

The Government of New Brunswick added  Lemtrada (alemtuzumab), by Sanofi Genzyme, to the New Brunswick Prescription Drug Program (NBPDP) through special authorization for eligible patients with relapsing-remitting multiple sclerosis (RRMS). ... Read more

August 26, 2016August 26, 2016

900 Cyclists to Raise Money for MS in Biking Event in Quebec This Weekend

News

The Quebec Division of the Multiple Sclerosis Society of Canada (MSSC)  announced that this year’s 27th Medavie Blue Cross MS Bike, a fundraising bike ride on roads ... Read more

August 25, 2016August 25, 2016

Teva’s New Copaxone Formulation for RRMS Approved by Health Canada

News

Health Canada has approved Teva Canada Innovation‘s three-time weekly 40 mg/mL injection of Copaxone (glatiramer acetate) that allows less frequent dosing for patients with relapsing-remitting multiple sclerosis (RRMS). ... Read more

July 26, 2016July 26, 2016

‘I am Cured,’ Says Woman with Aggressive Form of MS After Receiving HSCT in Canada

Columns, What's Important Now -- An MS Column by Ian Franks

An entry in the comments section of Multiple Sclerosis News Today caught my attention a couple of weeks ago, and peaked my interest. It was a ... Read more

May 27, 2016May 27, 2016

Report Highlights Series of Changes Needed from Canadian Employers and Government to Improve MS Patients’ Lives

News

A new report by the Conference Board of Canada’s Canadian Alliance for Sustainable Health Care (CASHC) notes that employers and the Canadian government are not giving enough support towards increasing ... Read more

December 29, 2015December 29, 2015

MS Patients Are Adequately, But Not Optimally, Treated for Depression

News

A new Canadian study, published in the International Journal of MS Care, has concluded that the majority of patients with concurrent multiple sclerosis (MS) and depression ... Read more

June 26, 2015June 26, 2015

Health Canada Non-Insured Health Benefits Program Approves AUBAGIO for Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis News, News

Genzyme Canada has announced that Health Canada has approved its 14 mg dose of AUBAGIO as an expedited exception benefit product through the federal health regulator’s ... Read more

June 23, 2015July 19, 2016

Canadian Drug Expert Committee Recommends MS Therapy LEMTRADA For Public Coverage

News

The Canadian Drug Expert Committee (CDEC) recently recommended that LEMTRADA (alemtuzumab) be included in provincial and other public drug plans for the management of adult patients with relapsing-remitting multiple sclerosis ... Read more

May 26, 2015May 26, 2015

AUBAGIO Included in Prince Edward Island Pharmacare

News

Canadian province Prince Edward Island (PEI) has approved the inclusion of Aubagio (teriflunomide) 14 mg in the PEI Pharmacare’s provincial drug formulary. This means that the ... Read more

December 2, 2014December 2, 2014

Aubagio for Relapsing-Remitting MS Now Funded in Alberta

News

Genzyme, a Sanofi company with over 30 years of dedication to researching and developing novel treatments for rare and orphan diseases, has just announced the Alberta ... Read more

September 24, 2014September 24, 2014

Multiple Sclerosis Summit in Quebec to Feature “Deepelling” As Encouragement for Active MS Lifestyles

News

International conferences on multiple sclerosis (MS) typically gather the most accomplished experts and leading biotech companies under one roof to exchange discoveries and celebrate new hope ... Read more